REGEN-COV antibody cocktail (casirivimab/imdevimab) for the treatment of inpatients with early hospital-acquired COVID-19: a single center experience
Faraone et al., Research Square, doi:10.21203/rs.3.rs-1170976/v1
https://c19early.org/faraone.html